We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Age of Stored Blood Affects Cardiac Surgery Success

By HospiMedica staff writers
Posted on 31 Mar 2008
A new study has found that cardiac surgery patients who received transfusions of blood that had been stored for 2 weeks or less had lower rates of complications and death than those who received blood that was older.

Researchers at the Cleveland Clinic Foundation (OH, USA) examined data from 6,002 patients given red blood cell (RBC) transfusions during coronary artery bypass grafting (CABG), heart-valve surgery, or both between June 30, 1998, and January 30, 2006. More...
The researchers compared a total 2,872 cardiac surgery patients who received transfusion blood that had been donated within the previous 2 weeks with 3,130 cardiac surgery patients who received transfusion blood that had been donated more than 2 weeks earlier. Multivariable logistic regression with propensity-score methods was used to examine the effect of the duration of storage on outcomes.

The researchers found that the patients who were given older blood had a higher risk of dying in hospital than their newer blood counterparts were (2.8% versus 1.7%), and significantly more likely to need prolonged ventilation support, experience kidney failure, sepsis, or multiple organ failure. Mortality at one year was significantly less in patients given newer blood (7.4%) compared to those given older blood (11%). The investigators also discovered a direct dose response relationship between days of storage and the chances of a combination of serious complications or adverse events. After eliminating potential confounding factors, an analysis revealed that patients who had received older blood had a significantly higher rate of combined serious adverse events than those who received newer blood. The study was published in the March 20, 2008, issue of the New England Journal of Medicine (NEJM).

"In patients undergoing cardiac surgery, transfusion of red cells that had been stored for more than two weeks was associated with a significantly increased risk of postoperative complications as well as reduced short-term and long-term survival,” concluded lead author Colleen Koch, M.D., M.S., and colleagues of the department of cardiothoracic anesthesia.

Previous studies have already raised questions about the shelf life of donated blood and attendant risks to patients. Some hospitals have brought in new procedures to minimize the use of donated blood during cardiac surgery, such as reducing anemia before surgery, using drugs to stop bleeding during and after surgery, collecting blood lost by the patient during surgery to be reused, and even discharging patients with a lower than normal RBC count.


Related Links:
Cleveland Clinic Foundation

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
New
Gold Member
Platelet Function Analyzer
PL-12
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.